Identification, design and bio-evaluation of novel Hsp90 inhibitors by ligand-based virtual screening.
Heat shock protein 90 (Hsp90), whose inhibitors have shown promising activity in clinical trials, is an attractive anticancer target. In this work, we first explored the significant pharmacophore features needed for Hsp90 inhibitors by generating a 3D-QSAR pharmacophore model. It was then used to vi...
Main Authors: | JianMin Jia, XiaoLi Xu, Fang Liu, XiaoKe Guo, MingYe Zhang, MengChen Lu, LiLi Xu, JinLian Wei, Jia Zhu, ShengLie Zhang, ShengMiao Zhang, HaoPeng Sun, QiDong You |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3615092?pdf=render |
Similar Items
-
C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
by: Yingjuan Fan, et al.
Published: (2017-01-01) -
Universal primers for amplifying the complete coding sequence of cytoplasmic heat shock protein 90 (HSP90) in Lepidoptera
by: Peng Jun XU, et al.
Published: (2011-01-01) -
Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
by: Ting Li, et al.
Published: (2018-04-01) -
The universe of Hsp90
by: Stankiewicz Marta, et al.
Published: (2012-02-01) -
The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
by: Li Zihai, et al.
Published: (2010-10-01)